Roger Ulrich

Roger Ulrich is the founder of Calistoga Pharmaceuticals, Inc., founded in 2006, where the title held was Chief Development Officer from 2006 to 2011.
Dr. Ulrich was the founder of Phathom Pharmaceuticals, Inc., founded in 2018, where the title held was Chief Scientific Officer from 2018 to 2021.
Current jobs include Director at Aminex Therapeutics, Inc., Director at Remedy Pharmaceuticals, Inc. since 2016, Founding Director & Chief Scientific Officer at Acerta Pharma BV since 2013, Director at Kartos Therapeutics, Inc., and Director at Lengo Therapeutics, Inc. Former jobs include Director-Drug Safety Evaluation at Abbott Laboratories, Director at Aminex Plc, Senior Scientific Director at Merck Research Laboratories Massachusetts LLC from 2001 to 2003, Senior Scientist at Pharmacia & Upjohn, Inc., Senior Scientist at The Upjohn Co., Principal at Michigan State University, Principal at West Virginia State University, and Senior Advisor at Frazier Management LLC.
Education includes undergraduate and graduate degrees from Western Michigan University and a doctorate from West Virginia University.